
Holt Liberals pick 3 leaders for N.B. Power review
Social Sharing
The Holt government has announced the names of the three people who will lead a major review into the future of N.B. Power.
Two energy sector veterans and a former legislative watchdog will oversee the process, which will include public consultations and which is expected to wrap up with recommendations by next March.
It's a thorny task that must reconcile the public appetite for affordable power rates with the utility's need to undertake multibillion-dollar power station projects while managing a debt that now exceeds $5 billion.
"I know enough about the people in New Brunswick to know the will and strength of spirit," said Duncan Hawthorne, a former CEO of Bruce Power in Ontario and one of the three review leaders. "We've just to line it up in the right place.
"And the way to do that is to talk about options and have people buy into those, because it cannot be achieved without support. … There's a number of things that people will have to do in every single household in New Brunswick to make this transition work."
But Anne Bertrand, another review leader and a former provincial information and privacy commissioner who later sat on N.B. Power's board, said the recommendations will not be hostage to public opinion.
"The public does not have a veto," she told reporters.
"Comments and opinions will be taken into consideration, and are very important. We need to know what the expectations are. But the expectations can't dictate what the future of N.B. Power will be."
Michael Bernstein, the third appointee and a former CEO and investment fund manager in the energy sector, said the review team would point out the positives and negatives of each of its recommendations.
"Ultimately, it's up to the government and, really, New Brunswickers to decide what direction to take," he said.
Premier Susan Holt launched the review in the wake of a controversy over a perceived spike in the January power bills of some N.B. Power customers.
While that phenomenon has been explained by an independent audit, the utility has acknowledged it faces deeper, longer-term problems. These include the need for a multibillion dollar overhaul of the Mactaquac Dam, west of Fredericton, the utility's largest hydroelectric generating station.
The Point Lepreau nuclear plant in southern New Brunswick has also faced costly shutdowns, and the Belledune generating station in the north must be converted from coal burning to comply with federal climate policies.
Holt has not ruled out selling the utility, as a previous Liberal government tried to do in 2009, as one possible outcome of the review.
"We have not restricted the three leaders on discussing anything," Energy Minister René Legacy said Friday.
"If that's what New Brunswickers want to discuss, then we should have an open discussion about it, and put the subject to bed one way or another."
Hawthorne, who as CEO of Bruce Power oversaw one of the world's largest nuclear power sites, said the process will not be "a talking shop, where we will tell you what we're doing. We're really going to spend a fair amount of time listening to you."
Legacy said the review process would be covered by his department's budget, and the government committed to release more information soon about what the three review leaders will be paid.
The government is promising not only recommendations but a decision on those recommendations by March 31, 2026.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBC
an hour ago
- CBC
#TheMoment a Manitoba town opened its doors to wildfire evacuees
After a wildfire emergency displaced residents of northern Manitoba, the community of Swan River opened its doors to help those in need.


Globe and Mail
an hour ago
- Globe and Mail
Building on a strong foundation: Solmax launches Performance Materials
, /CNW/ -- Solmax is proud to announce the launch of their new Performance Materials platform, the next chapter in the integration of a long-standing legacy of TenCate Geosynthetics and Propex, now operating as a division of Solmax. For decades, both TenCate Geosynthetics and Propex built an Industrial Fabrics reputation next to their Geosynthetics activities with innovative, durable, and reliable solutions for the agricultural, recreational, and specialty markets. That commitment remains unchanged. As Performance Materials, the company carries forward the same trusted products, the same technical expertise, and the same customer-first philosophy – now with even greater global reach, resources, and opportunities through Solmax. Performance Materials provides high-performance solutions that support agriculture, recreation, and specialty industries. The company brings deep technical knowledge, practical innovation, and a hands-on approach to solving real-world challenges – helping customers work smarter, protect essential resources, and thrive in a changing world. "Performance Materials builds on a proud legacy of delivering practical, reliable solutions," said Bob Gilligan , CEO of Solmax. "We are investing in the future of technical textiles, strengthening our offering for the agriculture, recreation, and specialty markets while staying true to the values that earned our customers' trust." Backed by Solmax's global strength, Performance Materials is ready to take this legacy forward – with the same reliability, innovation, and partnership you've always counted on. Explore the new website and discover how Performance Materials is building on a proud history and shaping a strong future. Visit the website to learn more about Performance Material's products and solutions. About Performance Materials Performance Materials, a division of Solmax, delivers high-performance industrial fabrics for agriculture, recreation, and specialty markets. With decades of specialized expertise, we engineer durable, tested solutions designed to reduce waste, protect resources, and boost operational efficiency. Our materials serve a wide range of applications: from crop protection and containment to filtration, shade, and transportation, adapting to evolving customer needs and environmental demands. Grounded in technical know-how and driven by partnership, we go beyond supplying products. We solve problems. Performance Materials is committed to building safer, resilient and long-lasting solutions.


Globe and Mail
2 hours ago
- Globe and Mail
UnitedHealth (UNH) CEO Hemsley Vows Cost Controls as Q1 Earnings Fall Short
UnitedHealth's (UNH) new CEO, Steve Hemsley, opened his tenure by apologizing for the company's first earnings miss since 2008, pledging to restore shareholder confidence and address rising care costs. Hemsley replaced Andrew Witty after the first-quarter shortfall, which was driven by unexpectedly high costs in the Medicare Advantage unit, prompting a suspension of the 2025 guidance as UnitedHealth recalibrated its financial outlook. Market Overview: UnitedHealth missed first-quarter earnings estimates for the first time since 2008 Medicare Advantage costs rose above forecast, leading to suspension of 2025 guidance Optum Rx pharmacy benefit manager and UnitedHealthcare insurer units faced higher-than-expected care costs Key Points: Hemsley committed to incorporating elevated care-cost assumptions into future pricing Company will review forecasting models and risk metrics across all business units Optum Rx and UnitedHealthcare divisions to undergo a comprehensive audit of practices Looking Ahead: Investors will watch for more accurate guidance tied to real medical-cost trends Execution of cost-control measures and transparent reporting will be critical to restoring confidence Containment of Medicare Advantage losses will determine near-term profitability and trust Bull Case: The return of Stephen Hemsley as CEO brings experienced leadership to UnitedHealth. Hemsley previously led the company from 2006 to 2017 and has a deep understanding of its operations. He has pledged to earn back shareholder trust and optimize quality in its health services. Hemsley has initiated a comprehensive review of all company policies, practices, and performance measures, including controversial areas like Medicare Advantage risk adjustment and pharmacy benefits management. This review will involve independent experts, and approaches will be modified where appropriate. The company plans to factor in higher care costs into its private insurance plans and next year's Medicare Advantage plans, which could help stabilize margins in the future. Despite recent setbacks, UnitedHealth has a history of resilience and delivering long-term value to shareholders, as evidenced by a total shareholder return of nearly 16% over the past five years. Hemsley expressed optimism about the company's future, stating that many of the issues are within UnitedHealth's control and capacity to resolve. Bear Case: UnitedHealth reported its first earnings miss since 2008 in the first quarter, driven by unexpectedly high medical costs in its Medicare Advantage unit, leading to a suspension of its 2025 financial outlook. The company's shares plummeted significantly following the earnings miss and guidance withdrawal, reflecting a sharp decline in investor confidence. Shares fell nearly 20% in pre-market trading after the initial Q1 earnings report and later hit their lowest closing price since October 2020. Rising care utilization, particularly in Medicare Advantage where physician and outpatient care activity was described as "twice the rate we anticipated," is a major challenge, straining medical costs and profitability. The Optum Health division faced reimbursement gaps due to members transitioning from exited plans who required costlier care than expected. The abrupt departure of former CEO Andrew Witty and the suspension of guidance less than a month after a previous downgrade indicate significant internal challenges and uncertainty regarding the company's financial trajectory. UnitedHealth faces reputational challenges and scrutiny over various practices, which new CEO Hemsley has acknowledged and pledged to review. Hemsley emphasized that future financial guidance would explicitly reflect rising care costs and that all segments must improve forecasting accuracy to rebuild trust. Analysts noted that UnitedHealth must demonstrate tangible progress in cost containment and deliver consistent, reliable forecasts to stabilize its stock and regain investor confidence.